Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen

BACKGROUND: The objective of this study was to conduct an indirect treatment comparison between cabazitaxel, abiraterone and enzalutamide to determine the clinical efficacy and safety of cabazitaxel relative to comparators in the treatment of patients with metastatic castrate-resistant prostate canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fryzek, Jon P., Reichert, Heidi, Summers, Nicholas, Townes, Lindsay, Deuson, Robert, Alexander, Dominik D., Vanderpuye-Orgle, Jackie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895064/
https://www.ncbi.nlm.nih.gov/pubmed/29641566
http://dx.doi.org/10.1371/journal.pone.0195790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895064/
https://www.ncbi.nlm.nih.gov/pubmed/29641566
http://dx.doi.org/10.1371/journal.pone.0195790

Ejemplares similares